Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
The Big Market Report Take
The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- Seagate Technology: Why The 20% Plunge Is An OpportunitySeeking Alpha21m ago
Uniblock Raises $5.2M to Unify Blockchain InfrastructureDecrypt23m ago- Instacart: The Growth Stalled For NowSeeking Alpha24m ago
- Nvidia: Something Big Is ComingSeeking Alpha24m ago